Target Name: Transforming growth factor beta
NCBI ID: P6612
Review Report on Transforming growth factor beta Target / Biomarker Content of Review Report on Transforming growth factor beta Target / Biomarker
Transforming growth factor beta
Other Name(s): TGF-beta

Transforming Growth Factor Beta: Regulation of Cell Growth, Differentiation and Tissue Repair

Transforming growth factor beta (TGF-beta), also known as nonspecified subtype, is a protein that plays a crucial role in cell growth and differentiation. TGF-beta is a transmembrane protein that is involved in the regulation of cell growth, cell proliferation, and cell differentiation. It is a key regulator of the TGF-beta signaling pathway, which is a well-established framework for the regulation of cellular processes, including cell growth, cell differentiation, and tissue repair.

TGF-beta is a family of proteins that consists of four isoforms, including TGF-beta1, TGF-beta2, TGF-beta3, and TGF-beta4. These isoforms differ in their level of expression and their ability to induce cell proliferation. TGF- beta1 and TGF-beta2 are predominantly expressed in osteoclasts, which are cells that are responsible for breaking down bone tissue. TGF-beta3 and TGF-beta4 are predominantly expressed in smooth muscle cells (SMCs), which are responsible for maintain normal muscle function.

TGF-beta is involved in the regulation of cellular processes that are critical for tissue growth and development. One of its well-established functions is the regulation of cell proliferation. TGF-beta can induce the growth of cells by promoting the production of new Cyclins (Kaplan-Agarwal, 2012). This is done by the interaction of TGF-beta with its downstream target, the transcription factor Smad. TGF-beta can also induce the transformation of stem cells into cancer cells by promoting the production of oncogenic stem cell factor (CSCF) (Dong and Li, 2010).

TGF-beta is also involved in the regulation of cell differentiation. It can induce the production of cell-type-specific proteins by promoting the production of these proteins from the precursor protein, such as myoblast-specific actinin (MSA) (Wang et al ., 2018). This is done by the interaction of TGF-beta with its downstream target, the transcription factor Sox2.

TGF-beta is also involved in the regulation of tissue repair. It can promote the production of tissue repair proteins by promoting the production of these proteins from the precursor protein, such as collagen ( Liu et al., 2018). This is done by the interaction of TGF-beta with its downstream target, the transcription factor FGF1.

TGF-beta is a protein that is involved in a wide range of cellular processes that are critical for tissue growth and development. It is a key regulator of the TGF-beta signaling pathway, and it plays a crucial role in the regulation of cell proliferation , cell differentiation, and tissue repair. As a result, TGF-beta is an attractive drug target for the development of new therapies for a variety of diseases, including cancer, cardiovascular disease, and neurodegenerative diseases.

Protein Name: Transforming Growth Factor Beta (nonspecified Subtype)

The "Transforming growth factor beta Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about Transforming growth factor beta comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

Transglutaminase | Transient Receptor Potential Cation Channel (TRP) | Transient receptor potential cation channel subfamily V | Translation initiation factor IF-2-like, transcript variant X1 | Translocase of inner mitochondrial membrane 23 homolog B (yeast), transcript variant X1 | Translocon-associated protein (TRAP) complex | Transmembrane protein FLJ37396 | TRAP1 | TRAPP complex | TRAPPC1 | TRAPPC10 | TRAPPC11 | TRAPPC12 | TRAPPC13 | TRAPPC14 | TRAPPC2 | TRAPPC2L | TRAPPC3 | TRAPPC3L | TRAPPC4 | TRAPPC5 | TRAPPC6A | TRAPPC6B | TRAPPC8 | TRAPPC9 | TRARG1 | TRAT1 | TRAV1-2 | TRAV10 | TRAV11 | TRAV12-1 | TRAV12-2 | TRAV13-2 | TRAV14DV4 | TRAV19 | TRAV2 | TRAV20 | TRAV21 | TRAV22 | TRAV24 | TRAV25 | TRAV26-1 | TRAV26-2 | TRAV27 | TRAV3 | TRAV34 | TRAV38-2DV8 | TRAV39 | TRAV4 | TRAV41 | TRAV8-1 | TRAV8-2 | TRAV8-3 | TRAV8-4 | TRAV8-6 | TRAV9-1 | TRBC1 | TRBC2 | TRBD1 | TRBD2 | TRBJ1-1 | TRBJ1-2 | TRBJ1-3 | TRBJ1-4 | TRBJ1-5 | TRBJ1-6 | TRBJ2-1 | TRBJ2-2 | TRBJ2-2P | TRBJ2-3 | TRBJ2-4 | TRBJ2-5 | TRBJ2-6 | TRBJ2-7 | TRBV10-1 | TRBV10-2 | TRBV10-3 | TRBV11-1 | TRBV11-2 | TRBV11-3 | TRBV12-3 | TRBV12-4 | TRBV12-5 | TRBV13 | TRBV14 | TRBV15 | TRBV16 | TRBV17 | TRBV18 | TRBV19 | TRBV2 | TRBV20-1 | TRBV21-1 | TRBV21OR9-2 | TRBV22-1 | TRBV23-1 | TRBV24-1 | TRBV25-1 | TRBV27 | TRBV28